Purnayu Bio Science Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.81 Cr
- Revenue Growth 28.30%
- Profit Growth -68.96%
- Ebitda -8.77%
- Net Worth 16.10%
- Total Assets -3.71%
About Purnayu Bio Science
Purnayu Bio Science Private Limited (PBSPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 June 2014 and has a history of Ten years and seven months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.81 Cr.
Kilankaje Ashakiran and Manasa Bhat serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24233KA2014PTC074951
-
Company No.
074951
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Jun 2014
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Purnayu Bio Science?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kilankaje Ashakiran
|
Director | 20-Jun-2014 | Current |
|
Manasa Bhat
|
Director | 10-May-2017 | Current |
Financial Performance of Purnayu Bio Science.
Purnayu Bio Science Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 28.3% increase. The company also saw a substantial fall in profitability, with a 68.96% decrease in profit. The company's net worth Soared by an impressive increase of 16.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Purnayu Bio Science?
In 2023, Purnayu Bio Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Sri Vinayaka Cold Storage Private LimitedKilankaje Ashakiran is a mutual person
Charges (Loans)
₹38.11 M
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 3.81 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Jul 2017 | Canara Bank | ₹3.81 Cr | Open |
How Many Employees Work at Purnayu Bio Science?
Unlock and access historical data on people associated with Purnayu Bio Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Purnayu Bio Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Purnayu Bio Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
